1.92EUR
9.74 MEUR
14.91 MEUR
4.29 M
About BIOVENTIX PLC
Sector
CEO
Peter J. Harrison
Website
Headquarters
Farnham
Founded
2003
ISIN
GB00B4QVDF07
FIGI
BBG00HY3PX26
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange BIOVENTIX PLC stocks are traded under the ticker 51B.
BIOVENTIX PLC is going to release the next earnings report on Oct 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BIOVENTIX PLC has a max estimate of 68.80 EUR and a min estimate of 68.80 EUR.
Yes, you can track BIOVENTIX PLC financials in yearly and quarterly reports right on TradingView.
51B net income for the last quarter is 4.64 M EUR, while the quarter before that showed 5.40 M EUR of net income which accounts for −14.09% change. Track more BIOVENTIX PLC financial stats to get the full picture.
BIOVENTIX PLC dividend yield was 3.95% in 2023, and payout ratio reached 94.63%. The year before the numbers were 4.41% and 103.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 51B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVENTIX PLC stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on BIOVENTIX PLC future price: according to them, 51B price has a max estimate of 68.80 EUR and a min estimate of 68.80 EUR. Read a more detailed BIOVENTIX PLC forecast: see what analysts think of BIOVENTIX PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVENTIX PLC EBITDA is 12.51 M EUR, and current EBITDA margin is 79.38%. See more stats in BIOVENTIX PLC financial statements.